Visannette

Medicinal product

(Invented) name

Visannette

Active substance (s)

Dienogestas

Strength

2 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

G03DB08, Dienogest

Marketing authorisation holder

Bayer AG, Vokietija

Date of authorisation

2010-05-24

Date of renewal

2014-11-10

Documents

1981_1_3 Visannette 2mg tab PCS PL 200525.docx

1981_1_3 Pakuotės lapelis 200525.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

NL/H/1569/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Dienogestas	2 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
32473	34858	1034858	lizdinė plokštelė	N28		Receptinis	LT/1/10/1981/001	Tiekiama	-	-	No	-	-	Download
41141	54898	1054898	lizdinė plokštelė	N84		Receptinis	LT/1/10/1981/002	Netiekiama	-	-	No	-	-
41142	54899	1054899	lizdinė plokštelė	N168		Receptinis	LT/1/10/1981/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2014-11-10	Perregistruotas
2010-05-24	Registruotas